Lately, GPL1 drugs have captured attention, not only for their role in managing type 2 diabetes and obesity but also due to concerns about eye health. Eye care experts recommend that people using these medications stay alert for any vision changes. Rising Use of GLP-1 Drugs GLP-1 receptor agonists have gained traction recently for managing…
In recent weeks, compounding pharmacies across the U.S. have experienced a notable uptick in activity as more patients seek urgently needed medications. Pharmacists report a significant increase in demand, mainly driven by ongoing shortages of key medications. Compounding pharmacies are essential in the healthcare system, providing customized medications for patients with unique needs. For instance,…
Many people hesitate to start their weight-loss journey with GLP-1 drugs such as Ozempic due to their dislike of needles. Now, there’s promising news for these cases: oral versions of these drugs are on the horizon. Currently, GLP-1 drugs such as semaglutide and tirzepatide are administered via weekly injections. However, new experimental pills are in…
Pfizer announced progress in developing a once-daily version of its weight loss pill, Danuglipron. Encouraging early-stage study results led the company to identify a favorable formulation regarding safety and bodily response. Further trials are planned for later this year to determine the optimal dose, with results expected in the first quarter of next year. Notably,…
A detailed pharmacovigilance investigation conducted by Kyung Hee University and Ajou University aimed to identify predictors associated with an increased risk of serious adverse events (SAEs) related to anti-obesity medications and to provide crucial evidence on drug safety. The Study The study analyzed 13,766 side effect reports from 2010 to 2019, uncovering important insights into…
New research from December 2023 indicates that adherence to anti-obesity medications remains a major challenge, with the vast majority of patients discontinuing treatment within one year. However, newer drugs like Wegovy are showing higher rates of long-term usage that may improve health outcomes. Research Shows 80% Discontinue Treatment by One Year According to new research…
A recent study published in 2023 investigated the cost-effectiveness of various anti-obesity medications for adolescents (). Given the rising prevalence of childhood and teen obesity, identifying affordable and efficient treatments is crucial. The Study Researchers from Columbia University and the University of Minnesota developed a microsimulation model to evaluate costs, health outcomes, and body mass…
As shortages of hot new weight-loss drugs like Ozempic and Wegovy persist due to surging consumer demand, patients are increasingly exploring older, time-tested alternatives that have stood the test of time. The Allure of the Next Big Thing The pharmaceutical world is witnessing a notable shift in prescription trends due to the scarcity of popular…
Type 2 diabetes is a chronic disease that has become more prevalent, with the number of people suffering from the condition estimated to be 422 million as of 2014 (). Diabetes is significantly linked to obesity and high blood pressure. This relationship is of great interest to researchers, and a recent study was carried out…
The Centers for Disease Control and Prevention (CDC) says that being overweight or having obesity increases the risk of getting cancer . To reduce this risk, it’s essential to maintain a healthy weight. But it is unknown whether overweight and obese people can reduce the risk of getting cancer through intentional weight loss. Thanks to…